Analysis of Clinical Application of China's First Batch of TYRX Absorbable Antibacterial Envelope

Analysis of Clinical Application of China's First Batch of TYRX Absorbable Antibacterial Envelope

This study is the first to use TYRX domesticly, reporting and summarizing its usage to validate its real-world effectiveness in CIED infection prevention.

This study is the first to use TYRX domesticly, reporting and summarizing its usage to validate its real-world effectiveness in CIED infection prevention.

Inclusion Criteria:

• All patients who received the TYRX absorbable antimicrobial envelopes at our hospital from December 2023 to September 2024

Exclusion Criteria:

• Allergies to the envelope materials or antimicrobial drugs (minocycline and other tetracyclines, rifampin)
• Existing infections at the CIED implantation site
• Pregnant or breastfeeding women
• children and adolescents